Prevention of postmenopausal osteoporosis and associated fractures: Clinical evaluation of the choice between estrogen and bisphosphonates.
Al-Azzawi
Farook
F
D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D016723:Bone Remodeling; D004164:Diphosphonates / Q000627:therapeutic use*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D005260:Female; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000517:prevention & control*
D050071:Bone Density Conservation Agents; D004164:Diphosphonates